Trials / Completed
CompletedNCT05342467
Gemeprost Versus Dinoprostone in First Trimester Miscarriages
Gemeprost Versus Dinoprostone in the Medical Management of First Trimester Miscarriages: a Randomized Controlled Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- National University of Malaysia · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Comparison between gemeprost and dinoprostone to evacuate first trimester miscarriages.
Detailed description
Women who are diagnosed with first trimester missed miscarriages are invited to participate in the study. They will be randomised to either gemeprost or dinoprostone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gemeprost 1 Mg Vaginal Pessary | Intravaginal gemeprost 1 mg inserted 3 hourly for maximum of 5 doses in 24 hours |
| DRUG | Dinoprostone 3 mg | Intravaginal dinoprostone 3 mg inserted 4 hourly for maximum of 3 doses in 24 hours |
Timeline
- Start date
- 2022-11-11
- Primary completion
- 2024-10-28
- Completion
- 2024-10-28
- First posted
- 2022-04-22
- Last updated
- 2025-06-11
Locations
2 sites across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT05342467. Inclusion in this directory is not an endorsement.